Wei Du
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 15
- Acute Myeloid Leukemia Research 12
- Molecular Biology top 10%
- DNA Repair Mechanisms 22
- Epigenetics and DNA Methylation 9
- RNA Interference and Gene Delivery 4
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 5
- Aging top 10%
- Immunology top 10%
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 4
- Co-authors
- Qishen PangSurya AmarachinthaReena RaniLimei WuPaul R. AndreassenXiaoling ZhangXue LiYi Zheng
- Partner nations
- United StatesChinaJapan
In The Last Decade
Wei Du
76 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Hematology 240
- Molecular Biology 919
- Cancer Research 199
- Aging 22
- Immunology 238
Countries citing papers authored by Wei Du
This map shows the geographic impact of Wei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Du more than expected).
Fields of papers citing papers by Wei Du
This network shows the impact of papers produced by Wei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Du. The network helps show where Wei Du may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 14 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 9 | |
| 9 | 2020 | 33 | |
| 10 | 2020 | 26 | |
| 11 | 2020 | 9 | |
| 12 | 2019 | 17 | |
| 13 | 2018 | 27 | |
| 14 | 2018 | 47 | |
| 15 | 2018 | 14 | |
| 16 | 2018 | 10 | |
| 17 | 2018 | 9 | |
| 18 | 2017 | 11 | |
| 19 | 2016 | 14 | |
| 20 | 1992 | 6 |
About Wei Du
Wei Du is a scholar working on Hematology, Immunology, Molecular Biology, Cancer Research and Oncology, having authored 78 papers that have together received 1.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (22 papers), Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (12 papers), Epigenetics and DNA Methylation (9 papers), Immune Cell Function and Interaction (7 papers), Carcinogens and Genotoxicity Assessment (5 papers), RNA Interference and Gene Delivery (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Hematology (240 citations), Molecular Biology (919 citations), Cancer Research (199 citations), Aging (22 citations) and Immunology (238 citations). Wei Du has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Qishen Pang, Surya Amarachintha, Reena Rani, Limei Wu, Paul R. Andreassen, Xiaoling Zhang, Xue Li, Yi Zheng, Fukun Guo and Jie Li. Their work appears in journals such as Blood, Leukemia, Stem Cells, Scientific Reports and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.